Please login to the form below
Anaveon
This page shows the latest Anaveon news and features for those working in and with pharma, biotech and healthcare.
Novartis and Syncona back new Swiss biotech Anaveon
Founders focused on IL-2 Receptor Agonists. Novartis' venture fund arm and Syncona are supporting new Switzerland-based immuno-oncology specialists Anaveon. ... re-direction of IL-2 activity in vivo, Anaveon has developed biologic approaches for the
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Featured jobs
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Publications director
-
Competitive salary and bonus scheme
-
Account director
-
Competitive salary and bonus scheme
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Experienced medical editor
-
Competitive salary and bonus scheme
-
Account Director, Medical Education
-
Salary TBC
- Account Director, Healthcare Communications
-
Salary TBC
-
Account Manager
-
£Competitive Salary
-
Account Director
-
£Competitive Salary
-
Senior External Communications Lead
-
£Competitive Salary
- Digital Associate Director - Medcomms
-
£65000 - £80000 per annum
-
Account Manager (PR)
-
Great Benefits
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
Subscribe to our email news alerts
- Immutep spikes on trial of its LAG-3 drug with Keytruda
- US backs Sanofi’s ‘fast-track’ coronavirus vaccine
- Coronavirus outbreak escalation could impact drug supply chain
- Researchers discover new antibiotic using AI
- Genital herpes vaccine candidate heads for human studies
- Roche’s Herceptin/Perjeta fixed-dose combo filed with FDA
- AVENIR GLOBAL appoints global healthcare lead
- Bedrock Group bolsters team with three key appointments
- AXON recognised for ‘excellence in wellbeing’ by Great Place to Work
- Celgene’s Revlimid scores NICE approval in follicular lymphoma
- Lilly’s Cyramza narrowly clears FDA adcomm vote for first-line NSCLC
- Menlo slumps as itching drug fails mid-stage trial
PMHub
Page & Page
For those who can imagine better, Page & Page is home to meaningful encounters of a marketing, communication and creative kind:...
Latest intelligence
- The ALS patient journey
- Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
- Equipping your medical affairs teams with solutions to navigate the healthcare landscape
- Dr Tyler Ray, OPEN Health Medical Communications...
- Can protein degraders unlock ‘undruggable’ drug targets?
- Exploring a new and exciting area of small-molecule drug discovery...
Quick links
Infographics
